Need professional-grade analysis? Visit stockanalysis.com
$37.84B
23.75
3,350
N/A
Shanghai RAAS Blood Products Co Ltd Class A (002252) trades on SHE in CNY. The company is classified in the Healthcare sector under the Biotechnology industry. The stock currently trades at CNY5.70, down 0.70% from the previous close.
Over the past year, 002252 has traded between a low of CNY5.66 and a high of CNY7.18. The stock has lost 15.8% over this period. It is currently 20.6% below its 52-week high.
Shanghai RAAS Blood Products Co Ltd Class A has a market capitalization of $37.84B, with a price-to-earnings ratio of 23.75.
Shanghai RAAS Blood Products Co., Ltd., together with its subsidiaries, produces and sells blood products in China and internationally. The company offers ALBURAAS, which is albumin prepared from human plasma; GAMARAAS, a human immunoglobulin product for intravenous injections; HEMORAAS, a human coagulation factor VIII product; PROTHORAAS, a human prothrombin complex; FIBRORAAS, a human fibrinogen; FIBINGLURAAS, a fibrin sealant for humans; and THROMBIRAAS, a human thrombin product. It also provides specific immune, human tetanus immunoglobulin, human rabies immunoglobulin, human immunoglobulin, hepatitis B human immunoglobulin, and other blood products. The company exports its products. Shanghai RAAS Blood Products Co., Ltd. was founded in 1988 and is headquartered in Shanghai, China.
Side-by-side comparison against top Healthcare peers.